Lifecore Biomedical, Inc. De (LFCR) Amortization of Deferred Charges (2023 - 2025)

Lifecore Biomedical's Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $6.8 million for Q2 2025.

• In Q2 2025, Amortization of Deferred Charges rose 12.68% year-over-year to $6.8 million; the TTM figure through May 2025 stood at $20.8 million (up 34.86% YoY), while the FY2025 annual figure was $20.2 million, up 31.12% from the prior year.
• Amortization of Deferred Charges was $6.8 million for Q2 2025 at Lifecore Biomedical, up from $5.2 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $6.8 million in Q2 2025 to a low of $3.0 million in Q3 2023.
• Historically, Amortization of Deferred Charges has averaged $4.5 million across 3 years, with a median of $4.4 million in 2024.
• Biggest YoY gain for Amortization of Deferred Charges was 60.01% in 2025; the steepest drop was 12.68% in 2025.
• A 3-year view of Amortization of Deferred Charges shows it stood at $3.1 million in 2023, then surged by 31.02% to $4.1 million in 2024, then soared by 65.95% to $6.8 million in 2025.
• The last three Amortization of Deferred Charges figures came in at $6.8 million (Q2 2025), $5.2 million (Q1 2025), and $4.1 million (Q4 2024), per Business Quant data.